CIA
CADL icon

Cape Investment Advisory’s Candel Therapeutics CADL Stock Holding History

Cape Investment Advisory’s Portfolio CADL Stock Details CADL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.72K Buy
+555
New +$4.19K ﹤0.01% 997

Other funds holding CADL

TWM
Tanager Wealth Management Goring On Thames, United Kingdom $1.15B AUM 19.91% 1-Year Est. Return
YIH
Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return
CPC
Cookson Peirce & Co Pittsburgh, Pennsylvania $3.04B AUM 94.11% 1-Year Est. Return
CSP
Cary Street Partners Richmond, Virginia $4.58B AUM 24% 1-Year Est. Return
PFSRSONJ
Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return
DC
Davenport & Co Richmond, Virginia $20.4B AUM 18.11% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return
SS
SBI Securities Tokyo, Japan $4.4B AUM 74.25% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return

Cape Investment Advisory's CADL Position: Q2 2026 in Review

Cape Investment Advisory opened a new position in Candel Therapeutics (CADL) in Q2 2026: 555 shares worth $5.72K. The stake represents ﹤0.01% of the portfolio and ranks #997 among its holdings.

12 funds tracked by Wall St. Rank hold CADL as of Q2 2026.

  • Cape Investment Advisory held 555 shares of Candel Therapeutics worth $5.72K as of Q2 2026.
  • Candel Therapeutics was a new Cape Investment Advisory position in Q2 2026.
  • Candel Therapeutics made up ﹤0.01% of Cape Investment Advisory's portfolio in Q2 2026, its #997 holding.
  • 12 funds tracked by Wall St. Rank held Candel Therapeutics as of Q2 2026.

Based on Cape Investment Advisory's 13F filing for Q2 2026, filed 23 Jul 2026.